Medicorp, Inc.

medicorpinc.com

Medicorp, Inc. is a nationwide physician recruiting company that was started in 1991. Now with over 2000 clients nationally we are one of the most seasoned and established companies you will find. Our physician recruiters have a combined 60+ years of invaluable consulting and physician placement experience that we are ready to put to work for you. Our focus and emphasis is and always has been on building long-term relationships with our clients and physicians.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ARTIFICIAL INTELLIGENCE (AI) MARKET IN HEALTHCARE SECTOR | PUSH FOR DIGITALIZATION IN HEALTHCARE TO BOOST GROWTH | TECHNAVIO

Business Wire | March 13, 2020

news image

Technavio has been monitoring the artificial intelligence (AI) market in healthcare sector and it is poised to grow by USD 5.16 bn during 2019-2023, progressing at a CAGR of over 28% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is concentrated, and the degree of concentration will accelerate during the forecast period. The push for digitalization in healthcare ...

Read More

Future of Healthcare

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

news image

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More

Health Technology

ONYX RELEASE THE ONLY FOUNDATIONAL HEALTH DATA INTEROPERABILITY PLATFORM IN THE MARKET, SAFHIR 3

Onyx | February 04, 2021

news image

Onyx Technology LLC is extremely pleased to announce today the release of SAFHIR 3, the only truly foundational health data interoperability platform in the market. Accessible to all health plans, SAFHIR 3 instantly enables compliance with the Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare and Medicaid Services (CMS)) data sharing rules while concurre...

Read More

Future of Healthcare

M1 MEDTECH ACCELERATOR PROGRAM OPENS APPLICATIONS TO EARLY-STAGE MEDICAL DEVICE COMPANIES

M1 MedTech | April 05, 2022

news image

M1 MedTech, a medical technology accelerator sponsored by Proxima Clinical Research, a contract research organization based out of the Texas Medical Center, announcedit is accepting applications for its fall cohort. M1 MedTech is looking for five to seven of the most promising early-stage medical device companies to participate in its three-month program. The program has closed its first fund and will be selecting companies over the summer for investments up to $100,000 as a combination...

Read More
news image

ARTIFICIAL INTELLIGENCE (AI) MARKET IN HEALTHCARE SECTOR | PUSH FOR DIGITALIZATION IN HEALTHCARE TO BOOST GROWTH | TECHNAVIO

Business Wire | March 13, 2020

Technavio has been monitoring the artificial intelligence (AI) market in healthcare sector and it is poised to grow by USD 5.16 bn during 2019-2023, progressing at a CAGR of over 28% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is concentrated, and the degree of concentration will accelerate during the forecast period. The push for digitalization in healthcare ...

Read More
news image

Future of Healthcare

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More
news image

Health Technology

ONYX RELEASE THE ONLY FOUNDATIONAL HEALTH DATA INTEROPERABILITY PLATFORM IN THE MARKET, SAFHIR 3

Onyx | February 04, 2021

Onyx Technology LLC is extremely pleased to announce today the release of SAFHIR 3, the only truly foundational health data interoperability platform in the market. Accessible to all health plans, SAFHIR 3 instantly enables compliance with the Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare and Medicaid Services (CMS)) data sharing rules while concurre...

Read More
news image

Future of Healthcare

M1 MEDTECH ACCELERATOR PROGRAM OPENS APPLICATIONS TO EARLY-STAGE MEDICAL DEVICE COMPANIES

M1 MedTech | April 05, 2022

M1 MedTech, a medical technology accelerator sponsored by Proxima Clinical Research, a contract research organization based out of the Texas Medical Center, announcedit is accepting applications for its fall cohort. M1 MedTech is looking for five to seven of the most promising early-stage medical device companies to participate in its three-month program. The program has closed its first fund and will be selecting companies over the summer for investments up to $100,000 as a combination...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us